Literature DB >> 23106270

Counterattacking drug-resistant tuberculosis: molecular strategies and future directions.

Liem Nguyen1, Michael R Jacobs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23106270      PMCID： PMC3968809          DOI： 10.1586/eri.12.97

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN： 1478-7210            Impact factor:   5.091


× No keyword cloud information.
  19 in total

Review 1.  Resisting resistance: new chemical strategies for battling superbugs.

Authors:  G D Wright
Journal:  Chem Biol       Date:  2000-06

2.  Mycobacterium tuberculosis and sulfamethoxazole susceptibility.

Authors:  Wendy Ong; Aina Sievers; David E Leslie
Journal:  Antimicrob Agents Chemother       Date:  2010-06       Impact factor: 5.191

Review 3.  A short history of dapsone, or an alternative model of drug development.

Authors:  Justin Barr
Journal:  J Hist Med Allied Sci       Date:  2010-10-21       Impact factor: 2.088

4.  Tuberculosis and trimethoprim-sulfamethoxazole.

Authors:  Pierre Forgacs; Nancy L Wengenack; Leslie Hall; Sarah K Zimmerman; Mark L Silverman; Glenn D Roberts
Journal:  Antimicrob Agents Chemother       Date:  2009-06-29       Impact factor: 5.191

5.  Antibiotic resistance is ancient.

Authors:  Vanessa M D'Costa; Christine E King; Lindsay Kalan; Mariya Morar; Wilson W L Sung; Carsten Schwarz; Duane Froese; Grant Zazula; Fabrice Calmels; Regis Debruyne; G Brian Golding; Hendrik N Poinar; Gerard D Wright
Journal:  Nature       Date:  2011-08-31       Impact factor: 49.962

6.  Susceptibility of Mycobacterium tuberculosis to sulfamethoxazole, trimethoprim and their combination over a 12 year period in Taiwan.

Authors:  Tsi-Shu Huang; Calvin M Kunin; Bo-Shiun Yan; Yao-Shen Chen; Susan Shin-Jung Lee; Wan Syu
Journal:  J Antimicrob Chemother       Date:  2011-11-29       Impact factor: 5.790

7.  Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism.

Authors:  Kristin N Adams; Kevin Takaki; Lynn E Connolly; Heather Wiedenhoft; Kathryn Winglee; Olivier Humbert; Paul H Edelstein; Christine L Cosma; Lalita Ramakrishnan
Journal:  Cell       Date:  2011-03-03       Impact factor: 41.582

Review 8.  Targeting drug tolerance in mycobacteria: a perspective from mycobacterial biofilms.

Authors:  Mohammad S Islam; Jacob P Richards; Anil K Ojha
Journal:  Expert Rev Anti Infect Ther       Date:  2012-09       Impact factor: 5.091

9.  Synthetic EthR inhibitors boost antituberculous activity of ethionamide.

Authors:  Nicolas Willand; Bertrand Dirié; Xavier Carette; Pablo Bifani; Amit Singhal; Matthieu Desroses; Florence Leroux; Eve Willery; Vanessa Mathys; Rebecca Déprez-Poulain; Guy Delcroix; Frédéric Frénois; Marc Aumercier; Camille Locht; Vincent Villeret; Benoit Déprez; Alain R Baulard
Journal:  Nat Med       Date:  2009-05-03       Impact factor: 53.440

10.  Meropenem-clavulanate is effective against extensively drug-resistant Mycobacterium tuberculosis.

Authors:  Jean-Emmanuel Hugonnet; Lee W Tremblay; Helena I Boshoff; Clifton E Barry; John S Blanchard
Journal:  Science       Date:  2009-02-27       Impact factor: 47.728
View more
  3 in total

1.  Deletion of sigB Causes Increased Sensitivity to para-Aminosalicylic Acid and Sulfamethoxazole in Mycobacterium tuberculosis.

Authors:  Shan-Shan Yang; Yang-Bo Hu; Xu-De Wang; Yun-Rong Gao; Kun Li; Xian-En Zhang; Shi-Yun Chen; Tian-Yu Zhang; Jing Gu; Jiao-Yu Deng
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

Review 2.  Antibiotic resistance mechanisms in M. tuberculosis: an update.

Authors:  Liem Nguyen
Journal:  Arch Toxicol       Date:  2016-05-09       Impact factor: 5.153

3.  The Pup-Proteasome System Protects Mycobacteria from Antimicrobial Antifolates.

Authors:  Marissa B Guzzo; Qing Li; Hoang V Nguyen; W Henry Boom; Liem Nguyen
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.